Kanya Rajangam

Executive Officer at Senti Biosciences.

Earliest Form D on file: Jun 2026

Filed Jun 4, 2026

Senti Biosciences

Gene medicines whose dose can be tuned after treatment

Biotech, South San Francisco CA

Named, Executive Officer.

$10M

sold of $40M offered

Network

At Senti Biosciences

9 people

Timothy Lu
Executive Officer, Director, signed as Chief Executive Officer
Brenda Cooperstone
Director
Bryan Baum
Director
Donald Tang
Director
Edward Mathers
Director
Feng Hsiung
Director

3 more at Senti Biosciences